In the News - Opus Genetics

September 6, 2022 : PharmaVoice: PharmaVoice 100 Entrepreneurs – Ben Yerxa

A profile of Opus CEO Dr. Ben Yerxa on founding Opus and his career in advancing therapies for ophthalmic conditions. » Full Story

August 1, 2022 : Life Science Leader: Venture Philanthropy Launches Biotech from Within

An interview with Opus CEO Dr. Ben Yerxa on founding the company and the Opus mission. » Full Story

June 6, 2022 : Eye on the Cure Podcast: Ash Jayagopal, PhD Interview

Foundation Fighting Blindness Host Ben Shaberman talks with Ash Jayagopal, chief scientific officer at Opus Genetics. » Full Story

December 2, 2021 : WRAL TechWire: StartUP Spotlight An interview with Opus CEO Dr. Ben Yerxa on Opus’ mission.

Opus Genetics recently announced it would open its third preclinical trial, just a few months after the company formed with a $19 million seed financing round led by the venture capital arm of the Foundation Fighting Blindness, the RD Fund. » Full Story